4//SEC Filing
Vida Ventures, LLC 4
Accession 0001104659-19-059645
CIK 0001720725other
Filed
Nov 3, 7:00 PM ET
Accepted
Nov 4, 7:04 PM ET
Size
8.7 KB
Accession
0001104659-19-059645
Insider Transaction Report
Form 4
Vida Ventures, LLC
10% Owner
Transactions
- Conversion
Common Stock, par value $0.001 per share
2019-11-04+778,468→ 778,468 total - Purchase
Common Stock, par value $0.001 per share
2019-11-04$16.00/sh+185,000$2,960,000→ 963,468 total - Conversion
Series B Convertible Preferred Stock
2019-11-04−778,468→ 0 total→ Common Stock, par value $0.001 per share (778,468 underlying)
Footnotes (1)
- [F1]These shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Series B Convertible Preferred Stock had no expiration date.
Documents
Issuer
Oyster Point Pharma, Inc.
CIK 0001720725
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001724489
Filing Metadata
- Form type
- 4
- Filed
- Nov 3, 7:00 PM ET
- Accepted
- Nov 4, 7:04 PM ET
- Size
- 8.7 KB